Skip to main content
OpenTrials
Completed

NCT Number: NCT04884867

A Psychosocial Tele-health Stigma Intervention for Youth Living With HIV in Vietnam

The overall goals of the study are to deepen understanding of the spectrum of stigma experienced by YLHIV in Vietnam, to develop a multi-level stigma intervention for YLHIV delivered by telephone, and to evaluate the feasibility, acceptability, and preliminary efficacy of the intervention on intra- and inter-personal stigma, psychological wellbeing, and treatment adherence.

The project has the following Specific Aims:

1. Adapt a psychosocial stigma-reduction intervention for YLHIV in Vietnam based on cognitive-behavioral therapy principles and delivered by telephone, using input from youth during intervention development. 2. Assess the feasibility, acceptability and preliminary efficacy of this innovative approach to reduce stigma, and improve psychosocial wellbeing and ART adherence among YLHIV through a small pre-post study. 3. Explore the multiple facets of stigma experienced by YLHIV in Vietnam and their relationships with ART adherence and psychosocial wellbeing via quantitative surveys and electronic adherence monitoring.

The study will assess the feasibility and acceptability of this approach among YLVIV in Vietnam, and generate preliminary evidence for the potential effect of the intervention on important endpoints including stigma, psychosocial wellbeing, adherence, CD4 count, and viral load (VL).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Acquired Immunodeficiency Syndrome Behavior Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Social Behavior Social Stigma Stigma, Social Urogenital Diseases Virus Diseases

Age range

18 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute for Social Development Studies

Hanoi, Vietnam

About this study

For the pilot, the investigators will recruit YLHIV on ART who self-report intrapersonal stigma and implement a 12-week pre-post intervention study in which participants will receive the phone-based intervention developed in the first phase. YLHIV will use an electronic adherence monitoring device for their ART medications.

In the pre-post intervention study, each of 40 patients will be followed for a total of 16 weeks. All patient subjects will be given an eCAP wireless pill container (WPC) that will be used to measure their adherence throughout the 16-week period. Study participation will involve two phases, with the following activities:

I. Adherence monitoring, pre-intervention period (Weeks 1-2). Once enrolled, the investigators will provide each subject with a WPC and instruction on correct use. The investigators will select one medication for each WPC. While subjects continue to receive care as usual, the investigators will collect their adherence data using the WPC.

II. Intervention period (Weeks 3-12). The intervention will be implemented for about 10 weeks; adherence data will be collected via WPCs through Week 16. They will remain blinded to the adherence information generated by the devices, as will their care providers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • are between 18 and 24 years old
  • are a patient at the OPC
  • are expected to remain in care at the OPC for 3 months minimum(?)
  • are currently on ART
  • have primary responsibility for taking their own medications,
  • self-report intrapersonal stigma via a brief screening questionnaire,
  • are able to complete a short phone call from the location where they intend to be when participating in coaching sessions,
  • agree to follow all study procedures, AND
  • provide informed consent.

Exclusion criteria

  • are below the age of 18 years or above the age of 24,
  • are not currently on ART,
  • live outside the clinic catchment area,
  • are identified as having severe mental health issues as identified through screening, OR
  • are not willing to provide informed consent.

Treatment and study plan

CBT-based supportive skills delivered by phone by lay coaches

Behavioral

8-10 weekly coaching sessions delivered by telephone

Primary outcomes

  1. Intrapersonal (self) Stigma

    Time frame: change between Week 1-Week 12

    modified 21-item self stigma subscale of Vietnam Stigma Index Studies instrument (People living with HIV: Stigma Index 2014; higher score=worse outcome)

  2. Interpersonal Stigma

    Time frame: change between Week 1 and Week 12

    modified 21-item enacted stigma subscale of Vietnam Stigma Index Studies instrument (People living with HIV: Stigma Index 2014; higher score=worse outcome)

  3. Depression

    Time frame: change between Week 1 and Week 12

    7-item depression subscale of the Depression, Anxiety and Stress Scale (DASS-21; higher score=worse outcome)

  4. Anxiety

    Time frame: change between Week 1 and Week 12

    7-item depression subscale of the Depression, Anxiety and Stress Scale (DASS-21; higher score=worse outcome)

  5. Adherence

    Time frame: Week 12 (endline)

    %≥95% on-time adherence

Sponsors and collaborators

Lead sponsor

University of New England

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Fogarty International Center of the National Institute of Health
  • Institute for Social Development Studies (ISDS)

Registry information

Official study title

"Sống Vui, Live Happily": A Psychosocial Tele-health Intervention to Address Multi-level Stigma Among Youth Living With HIV in Vietnam

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
May 13, 2021
Registry last updated
May 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.